Prevenar 20 is a vaccine to protect adults and children from 6 weeks of age against pneumonia (infection of the lungs) and invasive diseases (diseases that occur when a bacterium spreads through the body) caused by the bacterium *Streptococcus pneumoniae* (*S. pneumoniae*). It is also used in children from 6 weeks to 17 years of age to protect against acute otitis media (ear infection). Prevenar 20 contains parts from 20 different types of *S. pneumoniae*.
Therapeutic Indication
| Active immunisation for the prevention of invasive disease and pneumonia caused by *Streptococcus pneumoniae* in individuals 18 years of age and older.<br>See sections 4\.4 and 5\.1 for information on protection against specific pneumococcal serotypes.<br>Apexxnar should be used in accordance with official recommendations.<br> <br> | | --- |
Therapeutic Area (MeSH)
ATC Code
J07AL02
ATC Item
N/A
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Pneumococcal polysaccharide serotype 1 | N/A | Pneumococcal polysaccharide serotype 1 |
| Pneumococcal polysaccharide serotype 3 | N/A | Pneumococcal polysaccharide serotype 3 |
| Pneumococcal polysaccharide serotype 4 | N/A | Pneumococcal polysaccharide serotype 4 |
| Pneumococcal polysaccharide serotype 5 | N/A | Pneumococcal polysaccharide serotype 5 |
| Pneumococcal polysaccharide serotype 6A | N/A | Pneumococcal polysaccharide serotype 6A |
| Pneumococcal polysaccharide serotype 6B | N/A | Pneumococcal polysaccharide serotype 6B |
| Pneumococcal polysaccharide serotype 7F | N/A | Pneumococcal polysaccharide serotype 7F |
| Pneumococcal polysaccharide serotype 8 | N/A | Pneumococcal polysaccharide serotype 8 |
| Pneumococcal polysaccharide serotype 9V | N/A | Pneumococcal polysaccharide serotype 9V |
| Pneumococcal polysaccharide serotype 10A | N/A | Pneumococcal polysaccharide serotype 10A |
| Pneumococcal polysaccharide serotype 11A | N/A | Pneumococcal polysaccharide serotype 11A |
| pneumococcal polysaccharide serotype 12F | N/A | pneumococcal polysaccharide serotype 12F |
| Pneumococcal polysaccharide serotype 14 | N/A | Pneumococcal polysaccharide serotype 14 |
| Pneumococcal polysaccharide serotype 15b | N/A | Pneumococcal polysaccharide serotype 15b |
| Pneumococcal polysaccharide serotype 18C | N/A | Pneumococcal polysaccharide serotype 18C |
| Pneumococcal polysaccharide serotype 19A | N/A | Pneumococcal polysaccharide serotype 19A |
| Pneumococcal polysaccharide serotype 19F | N/A | Pneumococcal polysaccharide serotype 19F |
| Pneumococcal polysaccharide serotype 22F | N/A | Pneumococcal polysaccharide serotype 22F |
| Pneumococcal polysaccharide serotype 23F | N/A | Pneumococcal polysaccharide serotype 23F |
| Pneumococcal polysaccharide serotype 33F | N/A | Pneumococcal polysaccharide serotype 33F |
EMA Name
Prevenar 20 (previously Apexxnar)
Medicine Name
Prevenar 20 (previously Apexxnar)
Aliases
N/ANo risk management plan link.
